a synthetic small-molecule compound, directly binds to BCL6 BTB domain, significantly inhibiting the BCL6/SMRT interaction, reactivating BCL6 target genes & killing DLBCL cell lines via cell cycle arrest and apoptosis. Here, BCL6 is linked to diffuse large B-cell lymphoma.